Printer Friendly

CVS Caremark Corporation approves new share repurchase programme.

M2 PHARMA-September 20, 2012-CVS Caremark Corporation approves new share repurchase programme(C)2012 M2 COMMUNICATIONS

CVS Caremark Corporation (NYSE: CVS), a large integrated pharmacy company in the US, announced yesterday that the company's board of directors has approved a new share repurchase programme for up to USD6bn of the firm's outstanding common stock.

Effective immediately, the share repurchase authorisation allows the firm to impact the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.

The company expects the new share repurchase programme to be completed over a multi-year period.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2012 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Sep 20, 2012
Words:115
Previous Article:China Botanic Pharmaceutical Inc reports third quarter financial results.
Next Article:Medicure Inc reports financial results for fiscal 2012.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters